Study guide

9.2 Pathophysiology of Shock & Perioperative Fluid Therapy

Combined Medical Services Examination UPSC CMS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Logistics & Pattern

1.1 UPSC CMS Examination Overview & Eligibility 1.2 Two-Paper Written Exam Pattern & Negative Marking 1.3 Personality Test, Service Allocation & Career Paths

2 Chapter 2: General Medicine - Cardiology & Respiratory

2.1 Coronary Artery Disease & Acute Myocardial Infarction 2.2 Heart Failure & Cardiac Arrhythmias 2.3 Community-Acquired Pneumonia & Pulmonary Tuberculosis 2.4 COPD, Bronchial Asthma & Pulmonary Embolism

3 Chapter 3: General Medicine - Gastroenterology & Hepatology

3.1 Peptic Ulcer Disease & Upper GI Bleeding 3.2 Liver Cirrhosis & Portal Hypertension 3.3 Acute & Chronic Viral Hepatitis & Pancreatitis 3.4 Inflammatory Bowel Disease & Malabsorption Syndromes

4 Chapter 4: General Medicine - Nephrology & Endocrinology

4.1 Acute Kidney Injury & Chronic Kidney Disease 4.2 Glomerulonephritis, Nephrotic Syndrome & Electrolyte Imbalances 4.3 Diabetes Mellitus: Diagnosis, Complications & Management 4.4 Thyroid Disorders & Adrenal Gland Dysfunction

5 Chapter 5: General Medicine - Neurology, Haematology & Infection

5.1 Cerebrovascular Accidents (Stroke) & Epilepsy 5.2 Approach to Anaemia: Microcytic, Megaloblastic & Haemolytic 5.3 Acute & Chronic Leukaemias and Lymphomas 5.4 Tropical & Endemic Infections: Malaria, Typhoid & Dengue

6 Chapter 6: General Medicine - Emergency Medicine & Toxicology

6.1 Acute Anaphylaxis, Sepsis & Cardiopulmonary Resuscitation 6.2 Organophosphate, Paracetamol & Snakebite Toxicology 6.3 Common Dermatological & Psychiatric Manifestations in Internal Medicine 6.4 Musculoskeletal System & Adult Rheumatology

7 Chapter 7: Paediatrics - Neonatology & Child Growth

7.1 Newborn Care, Neonatal Resuscitation & APGAR Score 7.2 Prematurity, Low Birth Weight & Neonatal Jaundice 7.3 Infant & Child Growth & Developmental Milestones

8 Chapter 8: Paediatrics - Child Health & Nutrition

8.1 Protein-Energy Malnutrition (PEM) & Micronutrient Deficiencies 8.2 Universal Immunization Programme (UIP) & Child Vaccines 8.3 Pediatric Diarrhoea, Dehydration & Respiratory Emergencies 8.4 Birth Defects, Genetic Counseling, Autism & Paediatric Accidents/Poisoning

9 Chapter 9: Surgery - General Surgery, Wounds & Shock

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene 9.2 Pathophysiology of Shock & Perioperative Fluid Therapy 9.3 Acute Abdomen: Appendicitis, Peritonitis & Intestinal Obstruction 9.4 Classification, Resuscitation & Management of Thermal Burns 9.5 Medicolegal & Ethical Issues in Surgery

10 Chapter 10: Surgery - Surgical Specialties I

10.1 Inguinal, Femoral & Ventral Hernias 10.2 Benign Breast Diseases & Breast Carcinoma 10.3 Solitary Thyroid Nodule & Thyroid Carcinoma 10.4 Benign Prostatic Hyperplasia & Renal Calculi

11 Chapter 11: Surgery - ENT, Orthopaedics & Anaesthesia

11.1 Acute Otitis Media, Tonsillitis & Epistaxis 11.2 Cataract, Glaucoma & Red Eye Emergencies 11.3 Principles of Fracture Management & Common Dislocation 11.4 Principles of Local, Regional & General Anaesthesia 11.5 Neurosurgery: Raised ICP, Head Injury & CNS Lesions 11.6 Thoracic Surgery: Chest Trauma, Pleural & Lung Disease

12 Chapter 12: Obstetrics - Antenatal Care & Complications

12.1 Antenatal Care, Maternal Nutrition & Fetal Assessment 12.2 Preeclampsia, Eclampsia & Gestational Hypertension 12.3 Antepartum Haemorrhage: Placenta Previa & Abruptio Placentae 12.4 Anemia in Pregnancy & Gestational Diabetes Mellitus 12.5 Spontaneous & Recurrent Abortion: Recognition & Management

13 Chapter 13: Obstetrics & Gynaecology - Labor & PPH

13.1 Normal Labor Mechanisms & Partograph Monitoring 13.2 Malpresentations, Breech & Obstructed Labor 13.3 Postpartum Haemorrhage (PPH) Causes & Management 13.4 Puerperal Sepsis & Postnatal Maternal Care

14 Chapter 14: Gynaecology & Family Planning

14.1 Abnormal Uterine Bleeding & Uterine Fibroids 14.2 Cervical Screening (Pap Smear) & Pelvic Inflammatory Disease 14.3 Temporary & Permanent Contraceptive Methods in India 14.4 Medical Termination of Pregnancy (MTP): Law & Methods

15 Chapter 15: PSM - Epidemiology & Biostatistics

15.1 Principles of Epidemiology & Disease Transmission 15.2 Observational & Experimental Epidemiological Study Designs 15.3 Evaluation of Screening Tests: Sensitivity, Specificity & Predictive Value 15.4 Biostatistics: Sampling, Central Tendency & Significance Testing

16 Chapter 16: PSM - Disease Epidemiology & Programmes

16.1 Epidemiology & Control of TB, Malaria & Dengue 16.2 National Tuberculosis Elimination Programme & NVBDCP 16.3 Epidemiology of Hypertension, Diabetes & Cancer in India 16.4 Cold Chain Management & Vaccine Logistics in India 16.5 Genetics and Health: Inheritance, Screening & Counseling

17 Chapter 17: PSM - Health Planning & Environmental Health

17.1 Demography, Fertility Rates & Family Welfare Indicators 17.2 Safe Water Supply, Waste Disposal & Air Pollution 17.3 Occupational Health Hazards & Pneumoconioses 17.4 Health Care Delivery System, Ayushman Bharat & National Health Mission 17.5 International Health: WHO, Global Agencies & SDG 3 17.6 Medical Sociology & Health Education

9.2 Pathophysiology of Shock & Perioperative Fluid Therapy

Key Takeaways Explain This Topic AI

Shock is defined as systemic tissue hypoperfusion causing cellular hypoxia and lactic acidosis, broadly categorized into Hypovolemic, Cardiogenic, Obstructive, and Distributive (Septic, Anaphylactic, Neurogenic) shock.

Hypovolemic shock is hemodynamically characterized by low cardiac output (CO), low CVP/PCWP, and high systemic vascular resistance (SVR); hyperdynamic septic shock features high CO, low CVP/PCWP, and markedly reduced SVR.

ATLS classification of hemorrhagic shock divides blood loss into four classes: Class I (<15%), Class II (15-30%, tachycardia, narrowed pulse pressure), Class III (30-40%, explicit hypotension), and Class IV (>40%, severe hypotension, anuria, obtunded).

Hourly maintenance fluid requirements follow the 4-2-1 rule (4 mL/kg for first 10kg, 2 mL/kg for next 10kg, 1 mL/kg thereafter); balanced crystalloids (Ringer's Lactate) are preferred over 0.9% normal saline to prevent hyperchloremic metabolic acidosis.

Norepinephrine is the first-line vasopressor in septic shock (target MAP >= 65 mmHg), whereas Dobutamine is the primary inotropic agent in cardiogenic shock with low cardiac output.

Last updated: July 2026

9.2 Pathophysiology of Shock & Perioperative Fluid Therapy

UPSC CMS High-Yield Core Focus: Comprehensive mastery of shock classification, hemodynamic parameters (CO, SVR, CVP, PCWP), ATLS classification of hemorrhagic shock, perioperative fluid distribution, the 4-2-1 maintenance rule, crystalloid choices, and vasopressor/inotrope pharmacology.

1. Pathophysiology & Hemodynamic Classification of Shock

Shock is a state of systemic tissue hypoperfusion resulting from an acute imbalance between systemic oxygen delivery ( D O 2 DO_2 D O 2 ​ ) and cellular oxygen demand ( V O 2 VO_2 V O 2 ​ ). Cellular hypoxia shifts metabolism from aerobic respiration to anaerobic glycolysis, leading to accumulation of systemic lactic acid , ATP depletion, cell membrane pump failure, intracellular edema, organ collapse, and death.

Oxygen Delivery ( D O 2 ) = Cardiac Output ( C O ) × Arterial Oxygen Content ( C a O 2 ) \text{Oxygen Delivery } (DO_2) = \text{Cardiac Output } (CO) \times \text{Arterial Oxygen Content } (CaO_2) Oxygen Delivery ( D O 2 ​ ) = Cardiac Output ( CO ) × Arterial Oxygen Content ( C a O 2 ​ ) Cardiac Output ( C O ) = Heart Rate ( H R ) × Stroke Volume ( S V ) \text{Cardiac Output } (CO) = \text{Heart Rate } (HR) \times \text{Stroke Volume } (SV) Cardiac Output ( CO ) = Heart Rate ( H R ) × Stroke Volume ( S V )

Hemodynamic Profiles of Shock Types

Shock Category Primary Etiology Cardiac Output (CO) Preload (CVP / PCWP) Systemic Vascular Resistance (SVR) Mixed Venous S v O 2 SvO_2 S v O 2 ​

Hypovolemic Hemorrhage, plasma loss, severe dehydration, third-spacing Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) Increased ( ↑ ↑ \uparrow\uparrow ↑↑ ) Decreased ( ↓ \downarrow ↓ )

Cardiogenic Acute MI, acute valvular failure, severe arrhythmia, end-stage cardiomyopathy Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) Increased ( ↑ ↑ \uparrow\uparrow ↑↑ ) Increased ( ↑ ↑ \uparrow\uparrow ↑↑ ) Decreased ( ↓ \downarrow ↓ )

Obstructive Tension pneumothorax, cardiac tamponade, massive pulmonary embolism Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) Variable / High Increased ( ↑ ↑ \uparrow\uparrow ↑↑ ) Decreased ( ↓ \downarrow ↓ )

Distributive: Septic (Early) Vasodilation from endotoxins / inflammatory cytokines ( I L − 1 , T N F − α IL-1, TNF-\alpha I L − 1 , TNF − α ) Increased ( ↑ ↑ \uparrow\uparrow ↑↑ ) Decreased ( ↓ \downarrow ↓ ) Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) Increased ( ↑ \uparrow ↑ )

Distributive: Anaphylactic IgE-mediated histamine release → \rightarrow → capillary leak & venodilation Decreased ( ↓ \downarrow ↓ ) Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) Decreased ( ↓ \downarrow ↓ )

Distributive: Neurogenic Loss of sympathetic tone (spinal trauma above T6) Decreased ( ↓ \downarrow ↓ ) Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) Decreased ( ↓ ↓ \downarrow\downarrow ↓↓ ) Decreased ( ↓ \downarrow ↓ )

Critical Clinical Nuance: Neurogenic shock is uniquely characterized by hypotension combined with bradycardia (due to loss of sympathetic cardiac accelerator fibers T1–T4 and unopposed vagal tone) and warm, dry peripheries.

2. ATLS Classification of Hemorrhagic Shock

The Advanced Trauma Life Support (ATLS) guidelines classify hemorrhagic shock into four categories based on blood loss in a 70 kg adult (total blood volume ~5,000 mL or 70 mL/kg).

  • Diagnostic Parameter Class I (Mild) Class II (Moderate) Class III (Severe) Class IV (Life-Threatening)
  • Blood Loss (mL) <750 mL 750 – 1,500 mL 1,500 – 2,000 mL >2,000 mL
  • Blood Loss (% Volume) <15% 15 – 30% 30 – 40% >40%
  • Heart Rate (bpm) <100 (Normal) >100 (Tachycardia) >120 (Marked Tachycardia) >140 (Extreme Tachycardia)
  • Systolic Blood Pressure Normal Normal Decreased (Hypotension) Severely Decreased
  • Pulse Pressure (mmHg) Normal / Increased Narrowed Narrowed Severely Narrowed
  • Respiratory Rate (/min) 14 – 20 20 – 30 30 – 40 >35
  • Urine Output (mL/hour) >30 mL/h 20 – 30 mL/h 14 – 35 mL/h Negligible (<10 mL/h)
  • Mental Status Slightly anxious Mildly anxious Anxious / Confused Lethargic / Obtunded
  • Initial Fluid Replacement Crystalloids Crystalloids Crystalloids + Blood Massive Transfusion Protocol (1:1:1)

Key Exam Pearl: In Class II hemorrhagic shock, systolic blood pressure remains normal due to compensatory arterial vasoconstriction, but the pulse pressure narrows (diastolic pressure rises toward systolic). Explicit drop in systolic blood pressure defines Class III shock .

  • 3. Perioperative Fluid Therapy & Distribution
  • Total Body Water (TBW) Distribution

Total Body Water constitutes 60% of body weight in adult males (50% in females).

Intracellular Fluid (ICF): 2/3 of TBW (~40% of body weight).

Extracellular Fluid (ECF): 1/3 of TBW (~20% of body weight), further subdivided into:

Interstitial Fluid: 3/4 of ECF (~15% of body weight).

Intravascular Plasma: 1/4 of ECF (~5% of body weight).

Maintenance Fluid Requirements: The 4-2-1 Rule

For ongoing hourly maintenance intravenous fluids in fasting surgical patients:

First 10 kg of body weight: 4 m L / k g / h o u r 4 mL/kg/hour 4 m L / k g / h o u r ( 10 × 4 = 40 m L / h 10 × 4 = 40 mL/h 10 × 4 = 40 m L / h )

Second 10 kg of body weight (11–20 kg): 2 m L / k g / h o u r 2 mL/kg/hour 2 m L / k g / h o u r ( 10 × 2 = 20 m L / h 10 × 2 = 20 mL/h 10 × 2 = 20 m L / h )

Each additional kg above 20 kg: 1 m L / k g / h o u r 1 mL/kg/hour 1 m L / k g / h o u r

Calculation Example for a 70 kg Adult: Hourly Rate = ( 10 kg × 4 ) + ( 10 kg × 2 ) + ( 50 kg × 1 ) = 40 + 20 + 50 = 110 mL/hour \text{Hourly Rate} = (10\text{ kg} \times 4) + (10\text{ kg} \times 2) + (50\text{ kg} \times 1) = 40 + 20 + 50 = \textbf{110 mL/hour} Hourly Rate = ( 10 kg × 4 ) + ( 10 kg × 2 ) + ( 50 kg × 1 ) = 40 + 20 + 50 = 110 mL/hour

  • Daily Electrolyte Requirements
  • Water: 25 – 30 mL/kg/day
  • Sodium ( N a + Na^+ N a + ): 1 – 2 mmol/kg/day
  • Potassium ( K + K^+ K + ): 1 mmol/kg/day
  • Glucose: 50 – 100 g/day (prevents starvation ketosis and limits protein breakdown)
  • 4. Intravenous Fluid Formulations: Crystalloids vs. Colloids

Solution N a + Na^+ N a + (mmol/L) C l − Cl^- C l − (mmol/L) K + K^+ K + (mmol/L) C a 2 + Ca^{2+} C a 2 + (mmol/L) Buffer / Osmolality Key Clinical Considerations

0.9% Normal Saline 154 154 0 0 None (308 mOsm/L) Unbuffered. Large volumes cause hyperchloremic metabolic acidosis and renal vasoconstriction.

Ringer's Lactate (RL) 130 109 4 2.7 Lactate 28 mmol/L (273 mOsm/L) Balanced crystalloid. Preferred for trauma, general surgery, and burn resuscitation. Contraindicated in severe liver disease (impaired lactate metabolism).

Plasmalyte-A 140 98 5 0 Acetate 27 / Gluconate 23 (294 mOsm/L) Isotonic balanced crystalloid. Excellent for severe acid-base disturbances and liver dysfunction.

5% Dextrose (D5W) 0 0 0 0 None (252 mOsm/L) Provides free water. Dextrose rapidly metabolized, leaving hypotonic solution. Used for hypernatremia or hypoglycemia; NOT for resuscitation.

5% Human Albumin 130–145 130–145 <2 0 Natural Colloid (300 mOsm/L) Expands intravascular volume 1:1. Used in refractory septic shock, large-volume paracentesis, and severe hypoalbuminemia.

5. Vasopressors and Inotropes in Shock Management

When fluid resuscitation fails to achieve adequate arterial perfusion (Target Mean Arterial Pressure ≥ 65 m m H g \ge 65 mmHg ≥ 65 mm H g ), vasoactive medications are initiated. MAP = Diastolic BP + 1 3 ( Systolic BP − Diastolic BP ) \text{MAP} = \text{Diastolic BP} + \frac{1}{3}(\text{Systolic BP} - \text{Diastolic BP}) MAP = Diastolic BP + 3 1 ​ ( Systolic BP − Diastolic BP )

Pharmacology of Key Vasoactive Agents

Norepinephrine:

Mechanism: Potent α 1 \alpha_1 α 1 ​ -receptor agonist with mild β 1 \beta_1 β 1 ​ -inotropic activity.

Effects: Marked vasoconstriction elevating SVR and blood pressure with minimal change in heart rate.

Clinical Role: First-line vasopressor in Septic Shock and vasodilatory shock.

Epinephrine:

Mechanism: Potent α 1 \alpha_1 α 1 ​ , β 1 \beta_1 β 1 ​ , and β 2 \beta_2 β 2 ​ agonist.

Effects: Increases heart rate, cardiac contractility, and systemic vascular resistance.

Clinical Role: First-line drug for Anaphylactic Shock (0.5 mg IM 1:1,000 dilution in adults); second-line agent for refractory septic shock or cardiac arrest.

Dopamine:

Mechanism: Dose-dependent receptor affinity:

Low Dose ( 1 – 5 μ g/kg/min 1–5\ \mu\text{g/kg/min} 1–5 μ g/kg/min ): D 1 D_1 D 1 ​ dopaminergic receptors → \rightarrow → renal/splanchnic vasodilation.

Medium Dose ( 5 – 10 μ g/kg/min 5–10\ \mu\text{g/kg/min} 5–10 μ g/kg/min ): β 1 \beta_1 β 1 ​ adrenergic → \rightarrow → increased cardiac contractility and HR.

High Dose ( > 10 μ g/kg/min >10\ \mu\text{g/kg/min} > 10 μ g/kg/min ): α 1 \alpha_1 α 1 ​ adrenergic → \rightarrow → systemic vasoconstriction.

Clinical Role: Largely replaced by norepinephrine due to higher incidence of tachyarrhythmias.

Dobutamine:

Mechanism: Selective β 1 \beta_1 β 1 ​ -receptor agonist with mild β 2 \beta_2 β 2 ​ -vasodilation.

Effects: Potent inotropy (increases stroke volume) and chronotropy with mild reduction in SVR (inodilator).

Clinical Role: First-line inotropic agent in Cardiogenic Shock with low cardiac output and adequate blood pressure.

Vasopressin (Antidiuretic Hormone):

Mechanism: Direct stimulation of vascular smooth muscle V 1 V_1 V 1 ​ receptors.

Effects: Potent vasoconstriction independent of adrenergic receptors.

Clinical Role: Fixed-dose adjunct ( 0.03 u n i t s / m i n 0.03 units/min 0.03 u ni t s / min ) to norepinephrine in refractory septic shock to restore vascular tone.

Loading diagram... Hemodynamic Diagnostic Algorithm for Acute Shock States